Coordinate Direct Input of Both KRAS and IGF1 Receptor to Activation of PI3 kinase in KRAS-Mutant Lung Cancer

M Molina-Arcas, DC Hancock, C Sheridan, MS Kumar… - Cancer discovery, 2013 - AACR
Using a panel of non–small cell lung cancer (NSCLC) lines, we show here that MAP-ERK
kinase (MEK) and RAF inhibitors are selectively toxic for the KRAS-mutant genotype …
被引用次数：179 相关文章

Coordinate direct input of both KRAS and IGF1 receptor to activation of PI3 kinase in KRAS-mutant lung cancer.

M Molina-Arcas, DC Hancock, C Sheridan… - Cancer …, 2013 - europepmc.org
Using a panel of non-small cell lung cancer (NSCLC) lines, we show here that MEK and
RAF inhibitors are selectively toxic for the KRAS mutant genotype, while PI 3-kinase (PI3K) …
[PDF] psu.edu

[PDF][PDF] Coordinate Direct Input of Both KRAS and IGF1 Receptor to Activation of PI3 Kinase in KRAS-Mutant Lung Cancer

M Molina-Arcas, DC Hancock, C Sheridan, MS Kumar… - 2013 - Citeseer
Using a panel of non–small cell lung cancer (NSCLC) lines, we show here that MAP-ERK
kinase (MEK) and RAF inhibitors are selectively toxic for the KRAS-mutant genotype …
[PDF] iczhiku.com

[PDF][PDF] Coordinate Direct Input of Both KRAS and IGF1 Receptor to Activation of PI3 Kinase in KRAS-Mutant Lung Cancer

M Molina-Arcas, DC Hancock, C Sheridan, MS Kumar… - 2013 - picture.iczhiku.com
Using a panel of non–small cell lung cancer (NSCLC) lines, we show here that MAP-ERK
kinase (MEK) and RAF inhibitors are selectively toxic for the KRAS-mutant genotype …
[HTML] nih.gov

[HTML][HTML] Coordinate direct input of both KRAS and IGF1 receptor to activation of PI 3-kinase in KRAS mutant lung cancer

M Molina-Arcas, DC Hancock, C Sheridan… - Cancer …, 2013 - ncbi.nlm.nih.gov
Using a panel of non-small cell lung cancer (NSCLC) lines, we show here that MEK and
RAF inhibitors are selectively toxic for the KRAS mutant genotype, while PI 3-kinase (PI3K) …

Coordinate direct input of both KRAS and IGF1 receptor to activation of PI3 kinase in KRAS-mutant lung cancer

M Molina-Arcas, DC Hancock, C Sheridan… - Cancer …, 2013 - pubmed.ncbi.nlm.nih.gov
Using a panel of non-small cell lung cancer (NSCLC) lines, we show here that MAP-ERK
kinase (MEK) and RAF inhibitors are selectively toxic for the KRAS-mutant genotype …

Coordinate direct input of both KRAS and IGF1 receptor to activation of PI 3-kinase in KRAS mutant lung cancer

M Molina-Arcas, D Hancock, C Sheridan… - Cancer …, 2013 - oak.novartis.com
Using a panel of non-small cell lung cancer (NSCLC) lines, we show here that MEK and
RAF inhibitors are selectively toxic for the KRAS mutant genotype, while PI 3-kinase (PI3K) …
[PDF] researchgate.net

[PDF][PDF] Coordinate Direct Input of Both KRAS and IGF1 Receptor to Activation of PI3 Kinase in KRAS-Mutant Lung Cancer

M Molina-Arcas, DC Hancock, C Sheridan, MS Kumar… - 2013 - researchgate.net
Using a panel of non–small cell lung cancer (NSCLC) lines, we show here that MAP-ERK
kinase (MEK) and RAF inhibitors are selectively toxic for the KRAS-mutant genotype …
[PDF] academia.edu

[PDF][PDF] Coordinate Direct Input of Both KRAS and IGF1 Receptor to Activation of PI3 Kinase in KRAS-Mutant Lung Cancer

M Molina-Arcas, DC Hancock, C Sheridan, MS Kumar… - 2013 - academia.edu
Using a panel of non–small cell lung cancer (NSCLC) lines, we show here that MAP-ERK
kinase (MEK) and RAF inhibitors are selectively toxic for the KRAS-mutant genotype …

Coordinate Direct Input of Both KRAS and IGF1 Receptor to Activation of PI3 kinase in KRAS-Mutant Lung Cancer

M Molina-Arcas, DC Hancock, C Sheridan… - Cancer …, 2013 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Using a panel of non–small cell lung cancer
(NSCLC) lines, we show here that MAP-ERK kinase (MEK) and RAF inhibitors are …